Triple agonist therapy means more aggressive appetite suppression, potentially lower caloric intake, and greater lean mass loss risk
The production of medically essential drugs like Ozempic involves highly specialized facilities that require exacting expertise as well as a complex machinery setup that isnt widely available
This decline can contribute to fatigue, muscle loss, poor sleep, and stubborn fat accumulation
Additionally, the appetite-suppressing effects of both drugs may lead to inadequate nutritional intake or exacerbate weight loss beyond therapeutic targets, which could be harmful in some individuals
Biessels GJ, Verhagen C, Janssen J, van den Berg E, Zinman B, Rosenstock J, et al